Search

Your search keyword '"Quon, Harvey"' showing total 85 results

Search Constraints

Start Over You searched for: Author "Quon, Harvey" Remove constraint Author: "Quon, Harvey" Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
85 results on '"Quon, Harvey"'

Search Results

2. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

3. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

10. Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT)

12. Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy

13. Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial

14. Two versus five stereotactic ablative radiotherapy treatments for localized prostate cancer: A quality of life analysis of two prospective clinical trials

18. Every-other-day or once-a-week: Long-term efficacy outcomes of the multicenter randomised PATRIOT prostate SBRT trial.

27. Comparing the M.D. Anderson Symptom and Dysphagia Inventories for Head and Neck Cancer Patients.

30. Patient-Reported Outcomes-Guided Adaptive Radiation Therapy for Head and Neck Cancer.

31. Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer.

32. Determining Clinical Patient Selection Guidelines for Head and Neck Adaptive Radiation Therapy Using Random Forest Modelling and a Novel Simplification Heuristic.

33. Novel imaging classification system of nodal disease in human papillomavirus‐mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes.

34. Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials.

35. Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy.

36. Institutional review of glial tumors treated with chemotherapy: the first description of PCV-related pseudoprogression.

37. Framework for the quantitative assessment of adaptive radiation therapy protocols.

38. Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials.

40. The impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysis.

41. Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer

42. Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer: Late Toxicity

43. 454: SABR for favourable-risk prostate cancer: 10-year outcomes and second malignancies.

45. Long-Term Dynamics of Three Dimensional Telomere Profiles in Circulating Tumor Cells in High-Risk Prostate Cancer Patients Undergoing Androgen-Deprivation and Radiation Therapy.

46. Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy.

48. Metformin for Prevention of Anthropometric and Metabolic Complications of Androgen Deprivation Therapy in Prostate Cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled Trial.

Catalog

Books, media, physical & digital resources